Custom-made prosthesis replacement for reconstruction of elbow after tumor resection

Tang, Xiaodong; Guo, Wei; Yang, Rongli; Tang, Shun; Yang, Yi

doi:10.1016/j.jse.2009.01.022

Cited by 40 publications

(47 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[4][5][6] We present our experience of these implants after resection of primary malignant bone tumours. The oncological and functional outcome, and the complications and implant survival are presented.…”

Section: To 993) At Five Years the Use Of A Ther In The Treatment Omentioning

confidence: 99%

The results of total humeral replacement following excision for primary bone tumour

Puri

Gulia

2012

The Journal of Bone and Joint Surgery. British volume

View full text Add to dashboard Cite

Rarely, the extent of a malignant bone tumour may necessitate resection of the complete humerus to achieve adequate oncological clearance. We present our experience with reconstruction in such cases using a total humeral endoprosthesis (THER) in 20 patients (12 male and eight female) with a mean age of 22 years (6 to 59). We assessed the complications, the oncological and functional outcomes and implant survival. Surgery was performed between June 2001 and October 2009. The diagnosis included osteosarcoma in nine, Ewing's sarcoma in eight and chondrosarcoma in three. One patient was lost to follow-up. The mean follow-up was 41 months (10 to 120) for all patients and 56 months (25 to 120) in survivors. There were five local recurrences (26.3%) and 11 patients were alive at time of last follow-up, with overall survival for all patients being 52% (95% confidence interval (CI) 23.8 to 74) at five years. The mean Musculoskeletal Tumor Society score for the survivors was 22 (73%; 16 to 23). The implant survival was 95% (95% CI 69.5 to 99.3) at five years. The use of a THER in the treatment of malignant tumours of bone is oncologically safe; it gives consistent and predictable results with low rates of complication.

show abstract

Section: To 993) At Five Years the Use Of A Ther In The Treatment Omentioning

confidence: 99%

The results of total humeral replacement following excision for primary bone tumour

Puri

Gulia

2012

The Journal of Bone and Joint Surgery. British volume

View full text Add to dashboard Cite

show abstract

“…The complication rate following allograft reconstruction is high. There are few reports on the use of endoprosthetic reconstruction following proximal ulna tumour excision [19][20][21]. We have studied their use in a young patient population and conclude this method alleviates pain, provides good function, does not appear to compromise patient survival and provides a stable means of reconstruction.…”

Section: Discussionmentioning

confidence: 99%

“…There are few studies assessing the functional and oncological outcome, patient survival and prosthesis survivorship for proximal ulna endoprosthetic replacement following bone tumour resections [19][20][21]. The aim of this case series was to evaluate these outcome measures following custom-made proximal ulna endoprosthetic reconstruction after primary excision of bone tumours in young patients.…”

Section: Introductionmentioning

confidence: 99%

Proximal ulna endoprosthetic replacement for bone tumours in young patients

Sewell

Hanna

Pollock

et al. 2012

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Purpose The optimal reconstructive method after resection of malignant bone tumours of the proximal ulna is unknown. We report the outcome of endoprosthetic replacement in a young patient population. Methods This was a retrospective review of four patients [three males and one female; mean age 17.5 (range 11-31) years] who underwent limb salvage with a proximal ulnar endoprosthetic replacement following excision of malignant bone tumour. Mean follow-up was 85 (range months.

show abstract

“…Hanna et al [22] reported 18 patients who had a distal humeral endoprosthetic replacement following malignant bone tumour resection. There are few reports on the use of endoprosthetic reconstruction following proximal ulna tumour [23,24], excision and their outcome is largely unknown. The main difference between a distal humeral and proximal ulna endoprosthetic reconstruction is the integrity of the triceps mechanism in the former, wich should provide superior function.…”

Section: Discussionmentioning

confidence: 99%

A New Biological Technique of Elbow Reconstruction Following an Extensive Tumoral Resection of the Proximal Ulna

Sboui¹,

Jlalia²,

Riahi³

et al. 2017

Med Case Rep

View full text Add to dashboard Cite

The resection of malignant tumors often poses the challenge of reconstruction. The objective of this reconstruction is the restoration of a function. We present the case of a chondroblastic osteosarcoma of the ulna in a 27-year-old patient. The resection sacrificed part of the ulna. The conservation of part of the olecrane allowed an innovative reconstruction to be carried out by bringing the radial head into contact with the humeral trochlea. The preservation of elbow function was satisfactory.

show abstract

Custom-made prosthesis replacement for reconstruction of elbow after tumor resection

Cited by 40 publications

References 16 publications

The results of total humeral replacement following excision for primary bone tumour

The results of total humeral replacement following excision for primary bone tumour

Proximal ulna endoprosthetic replacement for bone tumours in young patients

A New Biological Technique of Elbow Reconstruction Following an Extensive Tumoral Resection of the Proximal Ulna

Contact Info

Product

Resources

About